<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-131735" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Non-Diabetic Hypoglycemia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ahmed</surname>
            <given-names>Fahad W.</given-names>
          </name>
          <aff>King Faisal Specialist Hospital and Research Center Madinah</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Majeed</surname>
            <given-names>Muhammad S.</given-names>
          </name>
          <aff>King Edward Medical University, Lahore</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kirresh</surname>
            <given-names>Omar</given-names>
          </name>
          <aff>Royal Sussex County Hospital, Brighton</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Fahad Ahmed declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Muhammad Majeed declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Omar Kirresh declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>17</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-131735.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Hypoglycemia is uncommonly seen in adults without diabetes mellitus. However, all patients should undergo evaluation and management who develop symptoms and/or signs of hypoglycemia (Whipple's triad), evidence of low blood glucose (55 mg/dL), and resolution of symptoms and/or signs after an increase in blood glucose level. This activity reviews the evaluation and treatment of non-diabetic hypoglycemia and highlights the role of the interprofessional team in evaluating and treating patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the etiology of non-diabetic hypoglycemia.</p></list-item><list-item><p>Review the pathophysiology of non-diabetic hypoglycemia.</p></list-item><list-item><p>Outline the evaluation and management of non-diabetic hypoglycemia.</p></list-item><list-item><p>Summarize the interprofessional team management of educating the patient with regards to non-diabetic hypoglycemia.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=131735&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=131735">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-131735.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Hypoglycemia is defined as a clinical condition when the venous blood glucose level is &#x0003c;55mg/dl (&#x0003c;3mmol/L), obtained if possible, at the time of the symptoms.<xref ref-type="bibr" rid="article-131735.r1">[1]</xref>&#x000a0;Hypoglycemia can be clinically classified according to its timing; it can be fasting, postprandial, or exercise-related. A workup for hypoglycemia should be initiated if the patient fulfills Whipple&#x02019;s triad; biochemical evidence of hypoglycemia, clinical signs and symptoms consistent with hypoglycemia, and resolution of these features by correcting blood glucose levels. Testing should be performed at the time of spontaneous development of symptoms, with documented low blood glucose levels, if feasible.</p>
        <p>Hypoglycemia is frequently observed in patients with diabetes mellitus but is uncommon in patients without diabetes. Hypoglycemia in patients without diabetes may be due to a variety of causes. Therefore, it is important to take a thorough clinical history and examination. Appropriate diagnostic tests should be undertaken to elucidate the cause of hypoglycemia.<xref ref-type="bibr" rid="article-131735.r1">[1]</xref>&#x000a0;Treatment is dependent on the cause of hypoglycemia. Hypoglycemia in children will also be briefly reviewed. In children, hypoglycemia is mostly due to inborn errors of metabolism (IEM) and is associated with multisystem involvement.</p>
      </sec>
      <sec id="article-131735.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>There are many causes of non-diabetic hypoglycemia. Hypoglycemia can be broadly divided into two main groups:</p>
        <list list-type="order">
          <list-item>
            <p>Insulin-mediated (hyperinsulinism)</p>
          </list-item>
          <list-item>
            <p>Independent of insulin</p>
          </list-item>
        </list>
        <p>Insulin-mediated (hyperinsulinism): The&#x000a0;endogenous cause of hypoglycemia due to hyperinsulinism in a non-diabetic adult is secondary to Insulinoma and islet cell hyperplasia (nesidioblastosis).<xref ref-type="bibr" rid="article-131735.r1">[1]</xref><xref ref-type="bibr" rid="article-131735.r2">[2]</xref>&#x000a0;Iatrogenic hyperinsulinism involves exogenous insulin intake or insulin secretagogues (sulphonylureas and glinides).<xref ref-type="bibr" rid="article-131735.r3">[3]</xref></p>
        <p>Independent of insulin: Insulin independent hypoglycemia includes alcohol, visceral failure (liver/renal failure), critical illness, primary adrenal failure, anterior pituitary failure, severe sepsis, cerebral malaria, anorexia nervosa, glycogen storage disease, post-bariatric surgery, mesenchymal tumors with elevated IGF-2 levels, autoimmune hypoglycemia secondary to anti-insulin or anti-insulin receptor antibodies and drugs. Hypoglycemia caused by drugs is very common<bold>.&#x000a0;</bold>Many drugs other than anti-hyperglycemic medications and alcohol have been reported.&#x000a0;Common medications&#x000a0;include quinolones, anti-malarial, glucagon, lithium, angiotensin-converting enzyme inhibitors, angiotensin receptor antagonists, non-selective B-blockers, etc.).<xref ref-type="bibr" rid="article-131735.r1">[1]</xref></p>
        <p>In children, hypoglycemia is mainly secondary to IEM. It includes glycogen storage disease, fatty acid oxidation defect, ketogenesis defects, and gluconeogenesis disorders. Galactosaemia and hereditary fructose intolerance are rare genetic disorders associated with the body&#x02019;s impaired ability to metabolize galactose and fructose, respectively.<xref ref-type="bibr" rid="article-131735.r4">[4]</xref><xref ref-type="bibr" rid="article-131735.r5">[5]</xref>&#x000a0;ABCC8, KCNJ11, GLUD1, GCK, HADH, UCP2, HNF1A, HNF4A, SLCA16A1, HK1, PGM1, PMM2 mutations can result in congenital hyperinsulinism, with KCNJ11 and ABCC8 mutations accounting for 40% to 50% of all cases.<xref ref-type="bibr" rid="article-131735.r6">[6]</xref></p>
      </sec>
      <sec id="article-131735.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Non-diabetic hypoglycemia is relatively uncommon as compared to hypoglycemia in patients with diabetes. A large retrospective review of 38,898 patients admitted to hospitals with non-critical illness showed the estimated frequency of 36 per 10000 admissions.<xref ref-type="bibr" rid="article-131735.r7">[7]</xref>&#x000a0;It was noted that patients with age above 65 years on admission were 50% more likely to have an episode of hypoglycemia.<xref ref-type="bibr" rid="article-131735.r7">[7]</xref></p>
        <p>The incidence of Insulinoma is estimated to be 0.4 per 100,000 person-years&#x000a0;with 59% female preponderance and age of 47 years at the surgery.<xref ref-type="bibr" rid="article-131735.r8">[8]</xref>&#x000a0;Hypoglycemia is a well-known complication of bariatric surgery, especially Roux-en-Y gastric bypass.<xref ref-type="bibr" rid="article-131735.r9">[9]</xref>&#x000a0;A population-based study noted a 2 to 7 fold increase in hospital admission due to hypoglycemia in patients who underwent bariatric surgery. However, the absolute risk&#x000a0;of hospitalization is very low&#x000a0;(approximately 0.2%) with hypoglycemia after gastric bypass surgery. In comparison, the general population risk was 0.04%.<xref ref-type="bibr" rid="article-131735.r10">[10]</xref><bold>&#x000a0;</bold></p>
        <p>Another study noted that less than 1% of the patient after&#x000a0;Roux-en-Y gastric bypass might require hospitalization due to hypoglycemia. Furthermore, less than 10% of patients may develop clinically significant hypoglycemia.<xref ref-type="bibr" rid="article-131735.r11">[11]</xref>&#x000a0;In a study involving 40 patients who had undergone Roux-en-Y gastric bypass, 75% of patients were noted to have asymptomatic hypoglycemia&#x000a0;on continuous glucose monitoring.<xref ref-type="bibr" rid="article-131735.r12">[12]</xref></p>
      </sec>
      <sec id="article-131735.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>There are several characteristic symptoms of hypoglycemia. Initial symptoms would be varied and non-specific. There is the activation of the autonomic nervous system leading to both adrenergic and cholinergic responses. Adrenergic symptoms include pallor, tremors, anxiety, and arterial hypertension. Anxiety and arterial hypertension are secondary to catecholamine release. Increased glucagon secretion leads to increased glucose production. The cholinergic response predominantly involves sweating, hunger, and paraesthesia.</p>
        <p>There is the production of counter-regulatory hormones, including reduced insulin production in insulin-independent hypoglycemia with increasing glucagon production. There is also the production of growth hormone and ACTH-induced cortisol in response to insulin-induced hypoglycemia. If hypoglycemia persists, it leads to neuroglycopenia symptoms comprising drowsiness, confusion, and visual impairment, followed by motor deficit, seizure, and loss of consciousness. Prolonged severe hypoglycemia can lead to multiple organ failure, cardiac arrhythmias, cardiac arrest, and permanent neurological damage.<xref ref-type="bibr" rid="article-131735.r13">[13]</xref><xref ref-type="bibr" rid="article-131735.r14">[14]</xref></p>
        <p>Iatrogenic hypoglycemia can be secondary to exogenous insulin or sulphonylureas. Therefore, there will be raised insulin and suppressed C-peptide levels in the former. In contrast, both insulin and C-Peptide will be raised with a positive sulphonylurea screen in the latter.</p>
        <p>Pathophysiology of non-insulin mediated hypoglycemia varies depending upon causative factors and is described as follows:<xref ref-type="bibr" rid="article-131735.r15">[15]</xref><xref ref-type="bibr" rid="article-131735.r16">[16]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Alcohol: It inhibits gluconeogenesis and glycogenolysis.&#x000a0;Patients intoxicated with alcohol have relatively low glycogen reserves, and alcohol also inhibits the shivering reflex, which leads to a poor endogenous response to hypoglycemia.</p>
          </list-item>
          <list-item>
            <p>Liver failure: It leads to diminished glycogen stores and impaired&#x000a0;gluconeogenesis.</p>
          </list-item>
          <list-item>
            <p>Renal failure: Hypoglycemia is rare but combined with the loss of renal gluconeogenesis and malnutrition,&#x000a0;reduced insulin clearance by the kidney, and reduced metabolism of medication, can cause hypoglycemia.</p>
          </list-item>
          <list-item>
            <p>Primary adrenal failure: Due to a lack of glucocorticoid hormone, there is decreased glucose production and increased insulin sensitivity.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Cerebral malaria: It is poorly understood. However, it is proposed that hypoglycemia can occur due to possible glucose consumption by parasites or the effect of quinine.</p>
          </list-item>
          <list-item>
            <p>Anterior pituitary failure: Hypoglycemia can occur due to corticotropic and somatotropic hormone deficiency.</p>
          </list-item>
          <list-item>
            <p>Drug-induced hypoglycemia: The cause of hypoglycemia can be multifactorial and varies with the type of drug.</p>
          </list-item>
          <list-item>
            <p>Infection: Severe infection can cause decreased glycogen storage and gluconeogenesis with excessive utilization.</p>
          </list-item>
          <list-item>
            <p>Neoplasia related (Non-Islets cell tumor): Hypoglycemia due to non-islet cell tumor is mediated via increased production of insulin-like growth factor II (IGF-2). IGF-2 stimulates insulin receptors due to its similarity to Insulin.</p>
          </list-item>
          <list-item>
            <p>Glycogen storage disease: Hypoglycemia occurs due to impaired glucose regulation by the liver.</p>
          </list-item>
          <list-item>
            <p>Insulin/insulin receptor antibodies: Hypoglycaemia occurs with elevated insulin levels and incompletely suppressed C-peptide levels. Insulin levels are more markedly elevated in those with insulin antibodies, whilst they are mildly elevated in those with insulin receptor antibodies.</p>
          </list-item>
          <list-item>
            <p>Gastric bypass surgery: The pathophysiology is still unclear. Hypoglycemia occurs in the postprandial phase. The mechanism is likely due to an altered rate of digestion and secretion of insulin.<xref ref-type="bibr" rid="article-131735.r17">[17]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-131735.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Hypoglycemia presents with varied symptoms. It involves autonomic (cholinergic and adrenergic) and, if it gets severe, leads to neuroglycopenic symptoms. Therefore, hypoglycemia fulfilling Whipple's triad (as described below) needs further evaluation. Whipple&#x02019;s triad includes the following:</p>
        <list list-type="order">
          <list-item>
            <p>Symptoms and signs consistent with hypoglycemia</p>
          </list-item>
          <list-item>
            <p>Biochemical evidence (capillary blood glucose or venous glucose) of hypoglycemia</p>
          </list-item>
          <list-item>
            <p>Resolution of symptoms with correction of hypoglycemia</p>
          </list-item>
        </list>
        <p>The patient may give a history of autonomic (shaking, sweating, palpitation, anxiety, hunger, paresthesis) and neuroglycopenic (drowsiness, feeling dizzy, generalized or focal weakness, seizure, and confusion) symptoms. It is important to take a detailed history, including the age of onset, nature, and timings of symptoms. Hypoglycemia is classified into reactive (post meals) or fasting hypoglycemia. Weight gain is seen in Insulinoma, whereas neoplasia is frequently associated with weight loss. The existence of underlying illnesses or conditions, drug history, and family history is important in history. It is important to find out about recent gastrointestinal surgery, e.g., gastric bypass. Other signs related to causative factors, including hyperpigmentation (Addison&#x02019;s disease), other auto-immune diseases, and a history of previous gastric bypass.</p>
        <p>Infants and children with hypoglycemia usually have an inborn error of metabolism (IEM), and it is associated with other features including hepatomegaly (glycogen storage disease), seizures (hereditary fructose intolerance), weight loss, vomiting and cataract (galactosemia), and short stature (growth hormone deficiency).<xref ref-type="bibr" rid="article-131735.r15">[15]</xref></p>
        <p>Signs of hypoglycemia are non-specific but include sweating, pallor, tachycardia, raised blood pressure, confusion, and impairment in cognition. These signs are reversible once blood glucose levels are normalized. Prolonged hypoglycemia can result in neurological damage, which can be permanent though this is rare. Physical evaluation involves full general physical examination, including weight and height measurement. It should include signs of auto-immune disease&#x02014;abdominal exam to look for hepatomegaly and previous surgical scars.</p>
      </sec>
      <sec id="article-131735.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Patients presenting with the features of Whipple&#x02019;s triad require further evaluation for the underlying cause of hypoglycemia. Initial laboratory investigations include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Urea &#x00026; electrolytes</p>
          </list-item>
          <list-item>
            <p>Liver function tests</p>
          </list-item>
          <list-item>
            <p>Fasting glucose</p>
          </list-item>
          <list-item>
            <p>Insulin, C-peptide, and proinsulin levels at the time of documented hypoglycemia</p>
          </list-item>
          <list-item>
            <p>Sulfonylurea and meglitinide screen</p>
          </list-item>
          <list-item>
            <p>Beta-hydroxybutyrate (BOHB)</p>
          </list-item>
          <list-item>
            <p>Early morning cortisol (if indeterminate, then a short Synacthen test should be arranged) and IGF-1 levels</p>
          </list-item>
          <list-item>
            <p>IGF-2 levels if there is a history of weight loss and malignancy</p>
          </list-item>
          <list-item>
            <p>Insulin/insulin receptor antibodies if elevated insulin levels/partially suppressed C-peptide</p>
          </list-item>
        </list>
        <p>
<bold>Reactive Hypoglycemia</bold>
</p>
        <p>It is normally postprandial and mostly due to Islet cell hyperplasia (enlarged and increased number of insulin-producing islet cells), autoimmune syndrome due to anti-insulin antibodies (rise in blood glucose post meals causes fluctuation in insulin production), glycogen storage disease (glucose regulation by the liver is altered) and gastric surgery (altered rate of digestion and secretion of insulin). A mixed meal test is performed for further evaluation in an adult with features suggestive of reactive hypoglycemia.</p>
        <p>
<bold>Fasting Hypoglycemia</bold>
</p>
        <p>Insulinoma, neoplasia, alcohol, and drugs are examples of conditions that lead to fasting hypoglycemia. A 72 hour fast is the gold standard test for the biochemical confirmation of insulinoma. Elevated insulin and C-peptide levels, in the setting of hypoglycemia, with a negative sulfonylurea screen support the diagnosis of endogenous overproduction of insulin(insulinoma). Insulin has an anti-ketogenic effect, and plasma beta-hydroxybutyrate levels remain less than 2.7mmol/L in insulinoma in prolonging fast.</p>
        <p>Computed tomography (CT), magnetic resonance imaging (MRI), and abdominal ultrasonography are primary investigations to localize insulinoma. In patients with endogenous hyperinsulinemic hypoglycemia with negative non-invasive localization studies, endoscopic ultrasonography (EUS) or selective arterial calcium stimulation test (SACST) with hepatic venous sampling can be performed for localization of smaller insulinomas. Endoscopic ultrasonography and selective arterial calcium stimulation test (SACST) have shown sensitivity for localization of 82&#x000a0;to 85% and 93%, respectively.<xref ref-type="bibr" rid="article-131735.r18">[18]</xref><xref ref-type="bibr" rid="article-131735.r19">[19]</xref></p>
        <p>Patients diagnosed with insulinoma should be screened for primary hyperparathyroidism and pituitary disease as part of Multiple endocrine neoplasia type 1.</p>
        <p>
<bold>Hypoglycemia Secondary to IEM</bold>
</p>
        <p>Inborn errors of metabolism are rare causes of hypoglycemia. Diagnostic workup is described as below,&#x000a0;and further testing should be conducted if suspected.<xref ref-type="bibr" rid="article-131735.r20">[20]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Glycogen storage disease: fasting hypoglycemia with hepatomegaly, which can be investigated with a glucose tolerance test with lactate and ketones measurement.</p>
          </list-item>
          <list-item>
            <p>Glucokinase activating mutation: postprandial hypoglycemia, which can be investigated with a mixed meal test.</p>
          </list-item>
          <list-item>
            <p>Monocarboxylate 1 mutation (MCT1): autosomal dominant associated with exercise-induced hypoglycemia</p>
          </list-item>
          <list-item>
            <p>Fatty acid oxidation defect: fasting hypoglycemia with raised cyclic phosphokinase and free fatty acid levels</p>
          </list-item>
          <list-item>
            <p>Gluconeogenesis disorder: fasting hypoglycemia with raised alanine, glycerol, lactate, and ketones.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-131735.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Generally, hypoglycemia can be managed in non-diabetic patients by eating smaller meals more regularly, with one to two snacks. Patients should be advised to avoid foods rich in sugar and avoid alcohol and caffeine. Treatment of non-diabetic hypoglycemia depends on causative factors.&#x000a0;Drugs causing hypoglycemia need to be discontinued. Reactive hypoglycemia post gastric bypass is controlled by dietary modification (low glycemic index diet) and acarbose (an alpha-glucosidase inhibitor). If disabling hypoglycemia persists post dietary and pharmacologic therapy, restoration of gastric constriction and subtotal pancreatectomy are recommended.<xref ref-type="bibr" rid="article-131735.r21">[21]</xref><xref ref-type="bibr" rid="article-131735.r22">[22]</xref></p>
        <p>Surgical resection is the primary treatment modality for insulinomas. In patients with increased surgical risk, medical therapies, such as diazoxide, somatostatin analogs (octreotide, lanreotide), verapamil, phenytoin, and everolimus [an inhibitor of the mammalian (mechanistic) target of rapamycin (mTOR)], have been used with some success.<xref ref-type="bibr" rid="article-131735.r23">[23]</xref></p>
        <p>In one study, ultrasound-guided fine needle chemical ablation with alcohol has successfully resolved hypoglycemia.<xref ref-type="bibr" rid="article-131735.r24">[24]</xref></p>
        <p>In infants and children with inborn errors of metabolism, the following measures should be taken:<xref ref-type="bibr" rid="article-131735.r15">[15]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Galactosemia: Milk-free diet</p>
          </list-item>
          <list-item>
            <p>Hereditary fructose intolerance: Eliminating fructose from the diet</p>
          </list-item>
          <list-item>
            <p>Glycogen storage disease: High protein with frequent low carbohydrate meals</p>
          </list-item>
          <list-item>
            <p>Hormone replacement in cortisol and growth hormone deficiency</p>
          </list-item>
          <list-item>
            <p>Nesidioblastosis: Diazoxide and surgical resection of the pancreas</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-131735.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnoses of hypoglycemia can be divided as low glucose without symptoms or normal glucose with symptoms. It is described in detail as follows:</p>
        <p>
<bold>Low Asymptomatic Glucose</bold>
</p>
        <p>The artefactual low glucose without any symptoms can be observed if a sample is taken without an antiglycolytic agent such as fluoride in the blood collection tube and delayed processing.<xref ref-type="bibr" rid="article-131735.r25">[25]</xref>&#x000a0;It is also observed in patients with leukemia or severe hemolytic disease due to the rapid glucose uptake.&#x000a0;</p>
        <p>
<bold>Symptomatic Normal Glucose</bold>
</p>
        <p>Normal plasma glucose with autonomic symptoms (tremors, palpitations, sweating, anxiety, and hunger) can be seen with other conditions as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Postprandial syndrome</p>
          </list-item>
          <list-item>
            <p>Cardiac disease (arrhythmia, valvular disease)</p>
          </list-item>
          <list-item>
            <p>Hyperthyroidism</p>
          </list-item>
          <list-item>
            <p>Pheochromocytoma</p>
          </list-item>
          <list-item>
            <p>Medications</p>
          </list-item>
          <list-item>
            <p>Psychiatric disease</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-131735.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of non-diabetic hypoglycemia varies, depending on the cause. Hypoglycemia secondary to&#x000a0;IEM needs lifelong treatment and follow-up. Hypoglycemia secondary to hormone deficiency responds well to replacement. Drug-induced or factitious hypoglycemia requires stopping the&#x000a0;offending medication.</p>
        <p>The prognosis of insulinoma is dependent on staging. Most patients with benign insulinomas have favorable outcomes with surgical resection. However, the prognosis is&#x000a0;variable&#x000a0;in patients with malignant insulinoma.<xref ref-type="bibr" rid="article-131735.r8">[8]</xref><xref ref-type="bibr" rid="article-131735.r26">[26]</xref>&#x000a0;Prognosis of non-islet tumor-related hypoglycemia depends if complete surgical resection is possible. Complete surgical resection can be curative in most cases. However, subtotal surgical resection may improve the symptoms. Recurrence of hypoglycemia is possible and may require medical treatment such as steroids.<xref ref-type="bibr" rid="article-131735.r27">[27]</xref></p>
        <p>The prognosis of hypoglycemia due to bariatric surgery is variable and may require reversal of the procedure.<xref ref-type="bibr" rid="article-131735.r16">[16]</xref></p>
      </sec>
      <sec id="article-131735.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Major complications of untreated hypoglycemia include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Anxiety</p>
          </list-item>
          <list-item>
            <p>Seizure</p>
          </list-item>
          <list-item>
            <p>Confusion or cognitive impairment</p>
          </list-item>
          <list-item>
            <p>Collapse and coma</p>
          </list-item>
          <list-item>
            <p>Cardiac arrhythmias and cardiac arrest</p>
          </list-item>
          <list-item>
            <p>Multi-organ failure</p>
          </list-item>
          <list-item>
            <p>Weight loss or gain</p>
          </list-item>
          <list-item>
            <p>Death</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-131735.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Hypoglycemia in a non-diabetic individual poses a significant diagnostic dilemma. The differential diagnosis is extensive, and management depends on the cause. Therefore, it requires careful evaluation of the patient. The patient's evaluation and management should involve an interprofessional healthcare team approach involving primary care clinicians (MDs, DOs, NPs, PAs), endocrinologists, specialist diabetes nurse educators, biochemists, pharmacists, radiologists, surgeons, and dieticians. The interprofessional approach is key to diagnosis, management, and improved patient outcomes. Finally, the team needs to coordinate and educate the patient regarding the best way to manage the condition, including the acute management of hypoglycemic episodes. This interprofessional&#x000a0;paradigm to care will yield the best patient outcomes. [Level 5]</p>
      </sec>
      <sec id="article-131735.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=131735&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=131735">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/hormones-and-body-chemistry/non-diabetic-hypoglycemia/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=131735">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/131735/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=131735">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-131735.s14">
        <title>References</title>
        <ref id="article-131735.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cryer</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Axelrod</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Grossman</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Heller</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Montori</surname>
                <given-names>VM</given-names>
              </name>
              <name>
                <surname>Seaquist</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Service</surname>
                <given-names>FJ</given-names>
              </name>
              <collab>Endocrine Society</collab>
            </person-group>
            <article-title>Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2009</year>
            <month>Mar</month>
            <volume>94</volume>
            <issue>3</issue>
            <fpage>709</fpage>
            <page-range>709-28</page-range>
            <pub-id pub-id-type="pmid">19088155</pub-id>
          </element-citation>
        </ref>
        <ref id="article-131735.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kapoor</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Flanagan</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>James</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Shield</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ellard</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hussain</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Hyperinsulinaemic hypoglycaemia.</article-title>
            <source>Arch Dis Child</source>
            <year>2009</year>
            <month>Jun</month>
            <volume>94</volume>
            <issue>6</issue>
            <fpage>450</fpage>
            <page-range>450-7</page-range>
            <pub-id pub-id-type="pmid">19193661</pub-id>
          </element-citation>
        </ref>
        <ref id="article-131735.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bonaventura</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Montecucco</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Dallegri</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Update on strategies limiting iatrogenic hypoglycemia.</article-title>
            <source>Endocr Connect</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>4</volume>
            <issue>3</issue>
            <fpage>R37</fpage>
            <page-range>R37-45</page-range>
            <pub-id pub-id-type="pmid">26099256</pub-id>
          </element-citation>
        </ref>
        <ref id="article-131735.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Perheentupa</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Raivio</surname>
                <given-names>KO</given-names>
              </name>
              <name>
                <surname>Nikkil&#x000e4;</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>Hereditary fructose intolerance.</article-title>
            <source>Acta Med Scand Suppl</source>
            <year>1972</year>
            <volume>542</volume>
            <fpage>65</fpage>
            <page-range>65-75</page-range>
            <pub-id pub-id-type="pmid">4579755</pub-id>
          </element-citation>
        </ref>
        <ref id="article-131735.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weinstein</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Steuerwald</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>De Souza</surname>
                <given-names>CFM</given-names>
              </name>
              <name>
                <surname>Derks</surname>
                <given-names>TGJ</given-names>
              </name>
            </person-group>
            <article-title>Inborn Errors of Metabolism with Hypoglycemia: Glycogen Storage Diseases and Inherited Disorders of Gluconeogenesis.</article-title>
            <source>Pediatr Clin North Am</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>65</volume>
            <issue>2</issue>
            <fpage>247</fpage>
            <page-range>247-265</page-range>
            <pub-id pub-id-type="pmid">29502912</pub-id>
          </element-citation>
        </ref>
        <ref id="article-131735.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Demirbilek</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hussain</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Congenital Hyperinsulinism: Diagnosis and Treatment Update.</article-title>
            <source>J Clin Res Pediatr Endocrinol</source>
            <year>2017</year>
            <month>Dec</month>
            <day>30</day>
            <volume>9</volume>
            <issue>Suppl 2</issue>
            <fpage>69</fpage>
            <page-range>69-87</page-range>
            <pub-id pub-id-type="pmid">29280746</pub-id>
          </element-citation>
        </ref>
        <ref id="article-131735.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nirantharakumar</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Marshall</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hodson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Narendran</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Deeks</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Coleman</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Ferner</surname>
                <given-names>RE</given-names>
              </name>
            </person-group>
            <article-title>Hypoglycemia in non-diabetic in-patients: clinical or criminal?</article-title>
            <source>PLoS One</source>
            <year>2012</year>
            <volume>7</volume>
            <issue>7</issue>
            <fpage>e40384</fpage>
            <pub-id pub-id-type="pmid">22768352</pub-id>
          </element-citation>
        </ref>
        <ref id="article-131735.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Service</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>McMahon</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Ballard</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study.</article-title>
            <source>Mayo Clin Proc</source>
            <year>1991</year>
            <month>Jul</month>
            <volume>66</volume>
            <issue>7</issue>
            <fpage>711</fpage>
            <page-range>711-9</page-range>
            <pub-id pub-id-type="pmid">1677058</pub-id>
          </element-citation>
        </ref>
        <ref id="article-131735.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Foster-Schubert</surname>
                <given-names>KE</given-names>
              </name>
            </person-group>
            <article-title>Hypoglycemia complicating bariatric surgery: incidence and mechanisms.</article-title>
            <source>Curr Opin Endocrinol Diabetes Obes</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>18</volume>
            <issue>2</issue>
            <fpage>129</fpage>
            <page-range>129-33</page-range>
            <pub-id pub-id-type="pmid">21297468</pub-id>
          </element-citation>
        </ref>
        <ref id="article-131735.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marsk</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jonas</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rasmussen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>N&#x000e4;slund</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Nationwide cohort study of post-gastric bypass hypoglycaemia including 5,040 patients undergoing surgery for obesity in 1986-2006 in Sweden.</article-title>
            <source>Diabetologia</source>
            <year>2010</year>
            <month>Nov</month>
            <volume>53</volume>
            <issue>11</issue>
            <fpage>2307</fpage>
            <page-range>2307-11</page-range>
            <pub-id pub-id-type="pmid">20495972</pub-id>
          </element-citation>
        </ref>
        <ref id="article-131735.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goldfine</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Patti</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>How common is hypoglycemia after gastric bypass?</article-title>
            <source>Obesity (Silver Spring)</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>24</volume>
            <issue>6</issue>
            <fpage>1210</fpage>
            <page-range>1210-1</page-range>
            <pub-id pub-id-type="pmid">27225595</pub-id>
          </element-citation>
        </ref>
        <ref id="article-131735.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kefurt</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Langer</surname>
                <given-names>FB</given-names>
              </name>
              <name>
                <surname>Schindler</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Shakeri-Leidenm&#x000fc;hler</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ludvik</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Prager</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Hypoglycemia after Roux-En-Y gastric bypass: detection rates of continuous glucose monitoring (CGM) versus mixed meal test.</article-title>
            <source>Surg Obes Relat Dis</source>
            <year>2015</year>
            <season>May-Jun</season>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>564</fpage>
            <page-range>564-9</page-range>
            <pub-id pub-id-type="pmid">25737101</pub-id>
          </element-citation>
        </ref>
        <ref id="article-131735.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cryer</surname>
                <given-names>PE</given-names>
              </name>
            </person-group>
            <article-title>Hypoglycemia in diabetes: pathophysiological mechanisms and diurnal variation.</article-title>
            <source>Prog Brain Res</source>
            <year>2006</year>
            <volume>153</volume>
            <fpage>361</fpage>
            <page-range>361-5</page-range>
            <pub-id pub-id-type="pmid">16876586</pub-id>
          </element-citation>
        </ref>
        <ref id="article-131735.r14">
          <label>14</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Mathew</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Thoppil</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <chapter-title>Hypoglycemia</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2022</year>
            <month>12</month>
            <day>26</day>
            <pub-id pub-id-type="pmid">30521262</pub-id>
          </element-citation>
        </ref>
        <ref id="article-131735.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wilson</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Non-diabetic hypoglycaemia: causes and pathophysiology.</article-title>
            <source>Nurs Stand</source>
            <year>2011</year>
            <month>Jul</month>
            <day>20-26</day>
            <volume>25</volume>
            <issue>46</issue>
            <fpage>35</fpage>
            <page-range>35-9</page-range>
            <pub-id pub-id-type="pmid">21894674</pub-id>
          </element-citation>
        </ref>
        <ref id="article-131735.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kittah</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Vella</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>MANAGEMENT OF ENDOCRINE DISEASE: Pathogenesis and management of hypoglycemia.</article-title>
            <source>Eur J Endocrinol</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>177</volume>
            <issue>1</issue>
            <fpage>R37</fpage>
            <page-range>R37-R47</page-range>
            <pub-id pub-id-type="pmid">28381450</pub-id>
          </element-citation>
        </ref>
        <ref id="article-131735.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salehi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vella</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>McLaughlin</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Patti</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Hypoglycemia After Gastric Bypass Surgery: Current Concepts and Controversies.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2018</year>
            <month>Aug</month>
            <day>01</day>
            <volume>103</volume>
            <issue>8</issue>
            <fpage>2815</fpage>
            <page-range>2815-2826</page-range>
            <pub-id pub-id-type="pmid">30101281</pub-id>
          </element-citation>
        </ref>
        <ref id="article-131735.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>R&#x000f6;sch</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lightdale</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Botet</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Boyce</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Sivak</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Yasuda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Heyder</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Palazzo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Dancygier</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Schusdziarra</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Localization of pancreatic endocrine tumors by endoscopic ultrasonography.</article-title>
            <source>N Engl J Med</source>
            <year>1992</year>
            <month>Jun</month>
            <day>25</day>
            <volume>326</volume>
            <issue>26</issue>
            <fpage>1721</fpage>
            <page-range>1721-6</page-range>
            <pub-id pub-id-type="pmid">1317506</pub-id>
          </element-citation>
        </ref>
        <ref id="article-131735.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Doppman</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shawker</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Gorden</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Norton</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Insulinomas: localization with selective intraarterial injection of calcium.</article-title>
            <source>Radiology</source>
            <year>1991</year>
            <month>Jan</month>
            <volume>178</volume>
            <issue>1</issue>
            <fpage>237</fpage>
            <page-range>237-41</page-range>
            <pub-id pub-id-type="pmid">1984311</pub-id>
          </element-citation>
        </ref>
        <ref id="article-131735.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Douillard</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mention</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dobbelaere</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wemeau</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Saudubray</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Vantyghem</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Hypoglycaemia related to inherited metabolic diseases in adults.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2012</year>
            <month>May</month>
            <day>15</day>
            <volume>7</volume>
            <fpage>26</fpage>
            <pub-id pub-id-type="pmid">22587661</pub-id>
          </element-citation>
        </ref>
        <ref id="article-131735.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carlson</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Schunder-Tatzber</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Neilson</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Hood</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Dietary sugars versus glucose tablets for first-aid treatment of symptomatic hypoglycaemia in awake patients with diabetes: a systematic review and meta-analysis.</article-title>
            <source>Emerg Med J</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>34</volume>
            <issue>2</issue>
            <fpage>100</fpage>
            <page-range>100-106</page-range>
            <pub-id pub-id-type="pmid">27644757</pub-id>
          </element-citation>
        </ref>
        <ref id="article-131735.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schneider</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>Villegas</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Blackburn</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Mun</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Critchlow</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>DB</given-names>
              </name>
            </person-group>
            <article-title>Laparoscopic gastric bypass surgery: outcomes.</article-title>
            <source>J Laparoendosc Adv Surg Tech A</source>
            <year>2003</year>
            <month>Aug</month>
            <volume>13</volume>
            <issue>4</issue>
            <fpage>247</fpage>
            <page-range>247-55</page-range>
            <pub-id pub-id-type="pmid">14561253</pub-id>
          </element-citation>
        </ref>
        <ref id="article-131735.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Okabayashi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shima</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sumiyoshi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kozuki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ogawa</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kobayashi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hanazaki</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and management of insulinoma.</article-title>
            <source>World J Gastroenterol</source>
            <year>2013</year>
            <month>Feb</month>
            <day>14</day>
            <volume>19</volume>
            <issue>6</issue>
            <fpage>829</fpage>
            <page-range>829-37</page-range>
            <pub-id pub-id-type="pmid">23430217</pub-id>
          </element-citation>
        </ref>
        <ref id="article-131735.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levy</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Topazian</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Callstrom</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Grant</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Vella</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>US-guided ethanol ablation of insulinomas: a new treatment option.</article-title>
            <source>Gastrointest Endosc</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>75</volume>
            <issue>1</issue>
            <fpage>200</fpage>
            <page-range>200-6</page-range>
            <pub-id pub-id-type="pmid">22078104</pub-id>
          </element-citation>
        </ref>
        <ref id="article-131735.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chan</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Swaminathan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cockram</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>Effectiveness of sodium fluoride as a preservative of glucose in blood.</article-title>
            <source>Clin Chem</source>
            <year>1989</year>
            <month>Feb</month>
            <volume>35</volume>
            <issue>2</issue>
            <fpage>315</fpage>
            <page-range>315-7</page-range>
            <pub-id pub-id-type="pmid">2914384</pub-id>
          </element-citation>
        </ref>
        <ref id="article-131735.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hirshberg</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Cochran</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Skarulis</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Libutti</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Alexander</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Wood</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kleiner</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Gorden</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Malignant insulinoma: spectrum of unusual clinical features.</article-title>
            <source>Cancer</source>
            <year>2005</year>
            <month>Jul</month>
            <day>15</day>
            <volume>104</volume>
            <issue>2</issue>
            <fpage>264</fpage>
            <page-range>264-72</page-range>
            <pub-id pub-id-type="pmid">15937909</pub-id>
          </element-citation>
        </ref>
        <ref id="article-131735.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bodnar</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Acevedo</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Pietropaolo</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Management of non-islet-cell tumor hypoglycemia: a clinical review.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>99</volume>
            <issue>3</issue>
            <fpage>713</fpage>
            <page-range>713-22</page-range>
            <pub-id pub-id-type="pmid">24423303</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
